Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

2-Aminoethyl Methylphosphonate, a Potent and Rapidly Acting Antagonist of GABAA-ρ1 Receptors

An Xie, Jun Yan, Lan Yue, Feng Feng, Fozia Mir, Heba Abdel-Halim, Mary Chebib, Guy C. Le Breton, Robert F. Standaert, Haohua Qian and David R. Pepperberg
Molecular Pharmacology December 2011, 80 (6) 965-978; DOI: https://doi.org/10.1124/mol.111.071225
An Xie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Yan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lan Yue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Feng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fozia Mir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heba Abdel-Halim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Chebib
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy C. Le Breton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert F. Standaert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haohua Qian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Pepperberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

2-Aminoethyl methylphosphonate (2-AEMP), an analog of GABA, has been found to exhibit antagonist activity at GABAA-ρ1 (also known as ρ1 GABAC) receptors. The present study was undertaken to elucidate 2-AEMP's action and to test the activities of 2-AEMP analogs. Whole-cell patch-clamp techniques were used to record membrane currents in neuroblastoma cells stably transfected with human GABAA-ρ1 receptors. The action of 2-AEMP was compared with that of 1,2,5,6-tetrahydropyridin-4-yl methylphosphinic acid (TPMPA), a commonly used GABAA-ρ1 antagonist. With 10 μM GABA, 2-AEMP's IC50 (18 μM) differed by less than 2.5-fold from that of TPMPA (7 μM), and results obtained were consistent with a primarily competitive mode of inhibition by 2-AEMP. Terminating the presentation of 2-AEMP or TPMPA in the presence of GABA produced a release from inhibition. However, the rate of inhibition release upon the termination of 2-AEMP considerably exceeded that determined with termination of TPMPA. Moreover, when presented at concentrations near their respective IC50 values, the preincubation period associated with 2-AEMP's onset of inhibition was much shorter than that for TPMPA. Analogs of 2-AEMP possessing a benzyl or n-butyl rather than a methyl substituent at the phosphorus atom, as well as analogs bearing a C-methyl substituent on the aminoethyl side chain, exhibited reduced potency relative to 2-AEMP. Of these analogs, only (R)-2-aminopropyl methylphosphonate significantly diminished the response to 10 μM GABA. Structure-activity relationships are discussed in the context of molecular modeling of ligand binding to the antagonist binding site of the GABAA-ρ1 receptor.

Footnotes

  • This work was supported by the National Institutes of Health National Eye Institute [Grants EY016094, EY001792]; the National Institutes of Health National Heart, Lung, and Blood Institute [Grant HL024530]; the Daniel F. and Ada L. Rice Foundation; Hope for Vision; the Macular Degeneration Research Program of the American Health Assistance Foundation; the Arnold and Mabel Beckman Initiative for Macular Research; Research to Prevent Blindness; and the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory, managed by UT-Battelle, LLC, for the United States Department of Energy.

  • Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.

    doi:10.1124/mol.111.071225.

  • ABBREVIATIONS:

    TPMPA
    1,2,5,6-tetrahydropyridin-4-yl methylphosphinic acid
    2-AEMP
    2-aminoethyl methylphosphonate
    3-APMPA
    3-aminopropyl methylphosphinic acid
    s-Bu
    secondary butyl
    Cbz
    carbobenzyloxy
    DCM
    dichloromethane
    DEAD
    diethyl azodicarboxylate
    DIPEA
    N,N-diisopropylethylamine
    THF
    tetrahydrofuran
    TLC
    thin-layer chromatography
    trityl
    triphenylmethyl.

  • Received January 14, 2011.
  • Accepted August 2, 2011.
  • U.S. Government work not protected by U.S. copyright
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 80 (6)
Molecular Pharmacology
Vol. 80, Issue 6
1 Dec 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
2-Aminoethyl Methylphosphonate, a Potent and Rapidly Acting Antagonist of GABAA-ρ1 Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

2-AEMP, a GABAA-ρ1 Antagonist

An Xie, Jun Yan, Lan Yue, Feng Feng, Fozia Mir, Heba Abdel-Halim, Mary Chebib, Guy C. Le Breton, Robert F. Standaert, Haohua Qian and David R. Pepperberg
Molecular Pharmacology December 1, 2011, 80 (6) 965-978; DOI: https://doi.org/10.1124/mol.111.071225

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

2-AEMP, a GABAA-ρ1 Antagonist

An Xie, Jun Yan, Lan Yue, Feng Feng, Fozia Mir, Heba Abdel-Halim, Mary Chebib, Guy C. Le Breton, Robert F. Standaert, Haohua Qian and David R. Pepperberg
Molecular Pharmacology December 1, 2011, 80 (6) 965-978; DOI: https://doi.org/10.1124/mol.111.071225
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Benzbromarone Relaxes Airway Smooth Muscle via BK Activation
  • Relapsed-Leukemia Model with NT5C2/PRPS1 Hotspot Mutations
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics